Leila Pirhaji: The medical potential of AI and metabolites
萊拉·皮爾哈吉: 人工智慧與代謝物的醫學潛力
Leila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases. Full bio
Double-click the English transcript below to play the video.
to treat many diseases.
could have a significant role
of the population globally,
受此疾病影響,
and leads to liver cancer
而且最後可發展為肝癌,
doesn't give us enough information
並不能給我們足夠的訊息,
many other molecules in our body.
還有許多其他的分子,
over 100,000 metabolites.
有超過十萬的代謝物。
that is supersmall in their size.
fructose, fats, cholesterol --
葡萄糖、果糖、脂肪、膽固醇——
in our metabolism.
from both our genes as well as lifestyle.
也透露出我們的生活作息。
to find treatments for many diseases.
就有必要瞭解代謝物,
I left medical school,
algorithms to analyze biological data.
演算法用來分析生物數據。
the metabolites in our body,
how they are changed in a disease
它們在疾病中如何變化,
changes to treat them.
has done this before:
沒有人做過這件事了:
we can measure their molecular mass
來測量它們的分子量。
10 molecules with the exact same mass,
分子量可能有十種之多,
identify all of them,
which could take decades
那有可能要花上數十年的時間,
intelligence, or AI, platform, to do that.
人工智慧來做這事。
information about metabolites
裡面有代謝物的相關訊息,
with other molecules.
相互作用的訊息,
as a meganetwork.
that are changed in a disease.
而產生變化的代謝物質量。
we don't know exactly what they are.
我們無法確切知道它們是什麼,
either the glucose, galactose or fructose.
不然就是半乳糖或是果糖,
all these ambiguities.
這些含糊不清的情形,
are connected to each other
what each metabolite mass is,
每個代謝物的分子量是多少。
and other metabolites
of disease mechanisms
effective therapeutics to target that.
找出有效的治療方法。
to bring this technology to the market
將這項技術帶入市場,
are working to discover
在 ReviveMed 生技公司
努力尋找重大疾病的療法,
that metabolites are key drivers for,
by accumulation of fats,
of metabolites in the liver.
不同類型的代謝物組成,
it's a huge epidemic with no treatment.
目前沒有任何治療方式,
is just one example.
hundreds of other diseases
data about metabolites
how changes in metabolites
smarter and smarter
for the right patients.
ABOUT THE SPEAKER
Leila Pirhaji - Biotech entrepreneurLeila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases.
Why you should listen
Leila Pirhaji is the founder of ReviveMed, an AI platform that can quickly and inexpensively characterize large numbers of metabolites (small molecules like glucose or cholesterol) from the blood, urine and tissues of patients. This allows for the detection of molecular mechanisms that lead to disease and the discovery of drugs that target these disease mechanisms.
Leila Pirhaji | Speaker | TED.com